Genetics & Genomics

November 11, 2013

Amish aid study of Parkinson genetics

Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles.

By Leigh MacMillan
stethoscope and money
October 17, 2013

Pharmacogenomic testing costs studied

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions.

By Paul Govern
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

By Bill Snyder
genetic sequence
April 18, 2013

BMI gene study expands to people of African ancestry

An international team of scientists, including six from Vanderbilt University, has identified the first unique genetic determinants of body mass index (BMI) in people of African ancestry.

By Bill Snyder
February 28, 2013

Potent genetic risk factor for breast cancer identified

Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.

By Bill Snyder
December 12, 2012

Genes, nutrients interact to shape traits

A new study identifies interactions between genes and nutrients that may participate in determining levels of cholesterol and triglycerides.

By Leigh MacMillan
November 1, 2012

Genomic research gains ad-“vantage” with new resources

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.
By Bill Snyder
November 1, 2012

Patients’ genetic data helps hone warfarin dosing

Warfarin dosing at Vanderbilt University Medical Center just got safer and more effective.
By Paul Govern
October 19, 2012

More gene links to breast cancer risk

Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.
By VUMC News and Communications
October 4, 2012

PREDICT helps pinpoint right statin for patient

When O.T. Hayes, 67, of Lebanon, Tenn., first starting seeing his cardiologist, David Hansen, M.D., for treatment of his coronary artery disease, it was hard to predict which of the various medications available would help control Haynes’ high cholesterol.
By Kathy Whitney
August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
By VUMC News and Communications
July 19, 2012

Research makes case for prospective genotyping

Vanderbilt researchers are investigating the potential benefits of prospective genetic testing for drug safety.
By Paul Govern
October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
By Craig Boerner